Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Cancer|Non-small-cell Lung Cancer|Breast Cancer
Interventions: DRUG: XL647|DRUG: XL147
Sponsor: Exelixis